CreditReports.dk
HomeScreen companies

SYNACT PHARMA ApS Financials, key figures and credit report

CVR number: 34459975 Established 2012 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Dronninggårds Alle 136, 2840 Holte joo@txppharma.com tel: 28447567
Gross profit -53 194.9 kDKK FY 2025 -102.5% vs 2024
EBIT -65 223.1 kDKK FY 2025 -81% vs 2024
Net debt -11 660.3 kDKK FY 2025 -32% vs 2024
Quick ratio 2.2 FY 2025 -0.5 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit-43 429.98-46 951.48-63 448.35-26 274.87-53 194.92
Employee benefit expenses-2 647.44-7 454.00-6 409.70-8 310.37-10 140.95
Total depreciation- 472.09- 816.86-1 011.14-1 449.43-1 887.27
EBIT-46 549.51-55 222.33-70 869.19-36 034.67-65 223.14
Other financial income0.08221.8453.61166.3961.84
Other financial expenses- 108.82- 279.81-93.34- 109.10- 151.64
Pre-tax profit-46 658.26-55 280.30-70 908.93-35 977.38-65 312.94
Income taxes5 501.635 500.005 500.005 500.005 500.00
Net earnings-41 156.63-49 780.30-65 408.93-30 477.38-59 812.94

Assets (kDKK)

2021
2022
2023
2024
2025
Development expenditure3 090.184 626.176 291.497 856.959 215.98
Intangible assets total3 090.184 626.176 291.497 856.959 215.98
Tangible assets total
Investments total199.49180.3193.4993.4993.49
Long term receivables total
Inventories total
Current trade debtors11 616.60
Current owed by particip. interest comp.483.57121.00
Prepayments and accrued income203.3146.0267.0611 522.022 005.31
Current other receivables1 631.682 828.292 694.163 502.563 407.83
Current deferred tax assets5 500.005 500.005 500.005 500.005 500.00
Short term receivables total7 334.9919 990.928 261.2321 008.1511 034.14
Cash and bank deposits2 919.4413 149.7512 138.688 833.4811 660.30
Cash and cash equivalents2 919.4413 149.7512 138.688 833.4811 660.30
Balance sheet total (assets)13 544.1037 947.1526 784.8937 792.0832 003.91

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital1 000.001 000.001 000.001 000.001 000.00
Share premium account17 060.0017 060.00
Asset revaluation reserve83 635.02160 761.18
Retained earnings-53 889.36-95 045.9979 994.8954 585.9679 108.59
Profit of the financial year-41 156.63-49 780.30-65 408.93-30 477.38-59 812.94
Shareholders equity total6 649.0333 994.8915 585.9625 108.5920 295.65
Provisions100.004 027.091 356.971 232.00
Non-current liabilities total
Current trade creditors5 363.012 439.606 062.0210 766.619 783.28
Current owed to group member1.02
Other non-interest bearing current liabilities1 531.041 412.671 109.82559.92692.99
Current liabilities total6 895.073 852.267 171.8411 326.5210 476.26
Balance sheet total (liabilities)13 544.1037 947.1526 784.8937 792.0832 003.91
Page generated